Quantcast
India's Panacea Biotec to produce 100 million Sputnik V doses annually: RDIF - Metro US

India’s Panacea Biotec to produce 100 million Sputnik V doses annually: RDIF

FILE PHOTO: File labelled "Sputnik V coronavirus disease (COVID-19) vaccine

MOSCOW (Reuters) – Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia’s Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.

RDIF did not say when production would begin.

(Reporting by Vladimir Soldatkin; Writing by Alexander Marrow, ediitng by Emelia Sithole-Matarise)

More from our Sister Sites